{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T01:20:38Z","timestamp":1775870438805,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T00:00:00Z","timestamp":1607904000000},"content-version":"vor","delay-in-days":13,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"UK aid"},{"DOI":"10.13039\/100004417","name":"Global Fund to Fight AIDS, Tuberculosis and Malaria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004417","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trop Med Health"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Seasonal malaria chemoprevention (SMC) using sulfadoxine-pyrimethamine and amodiaquine is an efficacious intervention for protection of children against <jats:italic>Plasmodium falciparum<\/jats:italic> malaria during the rainy season. In response to the global COVID-19 pandemic, Malaria Consortium adapted its SMC delivery model to ensure safety of distributors, data collectors and beneficiaries. We conducted a SMC monitoring survey in July 2020 in the states of Bauchi, Jigawa, Kano, Katsina, Sokoto and Yobe, with questions on COVID-19 prevention behaviours and symptoms, and belief in misinformation. We investigated the associations between receipt of information on COVID-19 by different sources, including from SMC distributors, and these three outcomes using logistic generalised estimating equations. We also considered moderation of effectiveness of message delivery by SMC distributors and adherence to use of face coverings.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We obtained a representative sample of 40,157 caregivers of eligible children aged 3\u201359\u2009months, of which 36,914 (91.92%) reported knowledge of COVID-19. The weighted proportions of respondents who correctly identified COVID-19 prevention behaviours and symptoms, and who reported belief in COVID-19 misinformation, were 80.52% (95% confidence interval [95% CI] 80.02\u201381.00), 81.72% (95% CI 81.23\u201382.20) and 22.90% (95% CI 22.24\u201323.57). Receipt of information on COVID-19 from SMC distributors during the campaign was significantly associated with higher odds of caregiver knowledge of COVID-19 prevention behaviours (odds ratio [OR] 1.78, 95% CI 1.64\u20131.94, <jats:italic>p<\/jats:italic> &lt; 0.001) and symptoms (OR 1.74, 95% CI 1.59\u20131.90, <jats:italic>p<\/jats:italic> &lt; 0.001) and lower odds of belief in COVID-19 misinformation (OR 0.92, 95% CI 0.85\u20131.00, <jats:italic>p<\/jats:italic> = 0.038). The associations between message delivery by SMC distributors and the three outcomes were moderated by their adherence to face covering use. Receipt of information by other sources used to deliver government public health messages, including radio and health facility workers, was also associated with knowledge of COVID-19.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Malaria Consortium\u2019s SMC programme was successfully adapted in the context of COVID-19 and was a conduit for high-quality public health messages. Standard SMC monitoring and evaluation activities can be adapted to gather evidence on emerging public health issues such as the global COVID-19 pandemic.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s41182-020-00288-7","type":"journal-article","created":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T10:04:47Z","timestamp":1607940287000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["COVID-19 knowledge, beliefs, prevention behaviours and misinformation in the context of an adapted seasonal malaria chemoprevention campaign in six northern Nigerian States"],"prefix":"10.1186","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0863-1061","authenticated-orcid":false,"given":"Sol","family":"Richardson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taiwo","family":"Ibinaiye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamilu","family":"Nikau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olusola","family":"Oresanya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madeleine","family":"Marasciulo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arantxa","family":"Roca-Feltrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Rassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olatunde","family":"Adesoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,12,14]]},"reference":[{"key":"288_CR1","volume-title":"Aeasonal malaria chemoprevention with sulfadoxine\u2013pyrimethamine plus amodiaquine in children: a field guide","author":"World Health Organization","year":"2013","unstructured":"World Health Organization. Aeasonal malaria chemoprevention with sulfadoxine\u2013pyrimethamine plus amodiaquine in children: a field guide. Geneva: World Health Organization; 2013. Available from: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/85726\/9789241504737_eng.pdf?sequence=1."},{"issue":"2","key":"288_CR2","doi-asserted-by":"publisher","first-page":"524","DOI":"10.4269\/ajtmh.17-0599","volume":"98","author":"T Druetz","year":"2018","unstructured":"Druetz T, Corneau-Tremblay N, Millogo T, et al. Impact evaluation of seasonal malaria chemoprevention under routine program implementation: a quasi-experimental study in Burkina Faso. Am J Trop Med Hyg. 2018;98(2):524\u201333. https:\/\/doi.org\/10.4269\/ajtmh.17-0599.","journal-title":"Am J Trop Med Hyg."},{"issue":"11","key":"288_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002175","volume":"13","author":"B Ciss\u00e9","year":"2016","unstructured":"Ciss\u00e9 B, Ba EH, Sokhna C, et al. Effectiveness of seasonal malaria chemoprevention in children under ten years of age in Senegal: a stepped-wedge cluster-randomised trial. PLoS Med. 2016;13(11):e1002175. https:\/\/doi.org\/10.1371\/journal.pmed.1002175.","journal-title":"PLoS Med."},{"issue":"8","key":"288_CR4","doi-asserted-by":"publisher","first-page":"4387","DOI":"10.1128\/AAC.04923-14","volume":"59","author":"I Zongo","year":"2015","unstructured":"Zongo I, Milligan P, Compaore YD, et al. Randomized noninferiority trial of dihydroartemisinin-piperaquine compared with sulfadoxine-pyrimethamine plus amodiaquine for seasonal malaria chemoprevention in Burkina Faso. Antimicrob Agents Chemother. 2015;59(8):4387\u201396. https:\/\/doi.org\/10.1128\/AAC.04923-14.","journal-title":"Antimicrob Agents Chemother."},{"key":"288_CR5","unstructured":"Givwell. Malaria Consortium \u2013 Seasonal Malaria Chemoprevention \u2013 November 2018 Version. 2018. Available from: https:\/\/www.givewell.org\/charities\/malaria-consortium\/November-2018-version."},{"key":"288_CR6","volume-title":"Our SMC programme","author":"Malaria Consortium","year":"2020","unstructured":"Malaria Consortium. Our SMC programme. 2020. Available from: https:\/\/www.malariaconsortium.org\/pages\/seasonal-malaria-chemoprevention\/our-smc-programme.htm."},{"key":"288_CR7","unstructured":"RBM Partnership to End Malaria. Adapting seasonal malaria chemoprevention in the context of COVID-19: operational guidance. Geneva: RBM Partnership to End Malaria; 2020. Available from: https:\/\/www.malariaconsortium.org\/media-downloads\/1336\/Adapting%20seasonal%20malaria%20chemoprevention%20in%20the%20context%20of%20COVID-19:%20operational%20guidance."},{"key":"288_CR8","volume-title":"Job aid: STEPS for using infection prevention and control to deliver SMC during COVID-19 pandemic","author":"Malaria Consortium","year":"2020","unstructured":"Malaria Consortium. Job aid: STEPS for using infection prevention and control to deliver SMC during COVID-19 pandemic. London: Malaria Consortium; 2020. Available from: https:\/\/www.malariaconsortium.org\/gallery-file\/06170924-10-smc_covid19jobaid.pdf."},{"key":"288_CR9","doi-asserted-by":"publisher","unstructured":"Olapegba PO, Ayandele O, Kolawole SO, et al. A preliminary assessment of novel coronavirus (COVID-19) knowledge and perceptions in Nigeria. https:\/\/doi.org\/10.1101\/2020.04.11.20061408.","DOI":"10.1101\/2020.04.11.20061408"},{"key":"288_CR10","doi-asserted-by":"publisher","unstructured":"Hager E, Odetokun IA, Bolarinwa O, et al. Knowledge, attitude, and perceptions towards the 2019 coronavirus pandemic: a bi-national survey in Africa. PLoS One. 2020;15(7):e0236918.\u00a0https:\/\/doi.org\/10.1371\/journal.pone.0236918.","DOI":"10.1371\/journal.pone.0236918"},{"key":"288_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10900-020-00881-1","volume":"7","author":"RC Reuben","year":"2020","unstructured":"Reuben RC, Danladi MMA, Saleh DA, et al. Knowledge, attitudes and practices towards COVID-19: an epidemiological survey in north-central Nigeria J Community Health. Jul. 2020;7:1\u201314. https:\/\/doi.org\/10.1007\/s10900-020-00881-1.","journal-title":"Jul"},{"key":"288_CR12","doi-asserted-by":"publisher","unstructured":"Nwafor JI, Aniukwu JK, Anozie BO, et al. Knowledge and practice of preventive measures against COVID-19 infection among pregnant women in a low-resource African setting. https:\/\/doi.org\/10.1101\/2020.04.15.20066894.","DOI":"10.1101\/2020.04.15.20066894"},{"key":"288_CR13","doi-asserted-by":"publisher","unstructured":"Isah MB, Abdulsalam M, Bello A, et al. Coronavirus disease 2019 (COVID-19): knowledge, attitudes, practices (KAP) and misconceptions in the general population of Katsina State, Nigeria. https:\/\/doi.org\/10.1101\/2020.06.11.20127936.","DOI":"10.1101\/2020.06.11.20127936"},{"issue":"8","key":"288_CR14","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/S1473-3099(20)30565-X","volume":"20","author":"The Lancet Infectious Diseases","year":"2020","unstructured":"The Lancet Infectious Diseases. The COVID-19 infodemic. Lancet Infect Dis. 2020;20(8):875. https:\/\/doi.org\/10.1016\/S1473-3099(20)30565-X.","journal-title":"Lancet Infect Dis."},{"key":"288_CR15","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.ijid.2020.06.067","volume":"98","author":"J Amzat","year":"2020","unstructured":"Amzat J, Aminu K, Kolo VI, et al. Coronavirus outbreak in Nigeria: burden and socio-medical response during the first 100\u2009days. Int J Infect Dis. 2020;98:218\u201324. https:\/\/doi.org\/10.1016\/j.ijid.2020.06.067.","journal-title":"Int J Infect Dis."},{"issue":"3\u20134","key":"288_CR16","first-page":"199","volume":"50","author":"SE Robertson","year":"1997","unstructured":"Robertson SE, Anker M, Roisin AJ, et al. The lot quality technique: a global review of applications in the assessment of health services and disease surveillance. World Health Stat Q. 1997;50(3\u20134):199\u2013209 Available from: https:\/\/apps.who.int\/iris\/handle\/10665\/55173.","journal-title":"World Health Stat Q."},{"key":"288_CR17","unstructured":"Centers for Disease Control and Prevention. Symptoms of coronavirus. 2020. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/symptoms-testing\/symptoms.html. Accessed 20 Sept 2020."},{"key":"288_CR18","unstructured":"Nigeria Centre for Disease Control. COVID-19 NIGERIA. 2020. https:\/\/covid19.ncdc.gov.ng\/. Accessed 20 Sept 2020."},{"key":"288_CR19","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.2307\/2531734","volume":"44","author":"SL Zeger","year":"1988","unstructured":"Zeger SL, Liang KY, Albert PS. Models for longitudinal data: a generalized estimating equation approach. Biometrics. 1988;44:1049\u201360. https:\/\/doi.org\/10.2307\/2531734.","journal-title":"Biometrics."},{"key":"288_CR20","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/s41562-020-0884-z","volume":"4","author":"JJB Bavel","year":"2020","unstructured":"Bavel JJB, Baicker K, Boggio PS, et al. Using social and behavioural science to support COVID-19 pandemic response. Nat Hum Behav. 2020;4:460\u201371. https:\/\/doi.org\/10.1038\/s41562-020-0884-z.","journal-title":"Nat Hum Behav."},{"issue":"6","key":"288_CR21","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1080\/17571472.2015.1113716","volume":"7","author":"AE While","year":"2015","unstructured":"While AE. Promoting healthy behaviours \u2013 do we need to practice what we preach? London J Prim Care (Abingdon). 2015;7(6):112\u20134. https:\/\/doi.org\/10.1080\/17571472.2015.1113716.","journal-title":"London J Prim Care (Abingdon)."},{"issue":"2","key":"288_CR22","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1093\/heapro\/dav003","volume":"31","author":"F Marais","year":"2016","unstructured":"Marais F, Minkler M, Gibson N, et al. A community-engaged infection prevention and control approach to Ebola. Health Promot Int. 2016;31(2):440\u20139. https:\/\/doi.org\/10.1093\/heapro\/dav003.","journal-title":"Health Promot Int."}],"container-title":["Tropical Medicine and Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s41182-020-00288-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s41182-020-00288-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s41182-020-00288-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T10:08:07Z","timestamp":1607940487000},"score":1,"resource":{"primary":{"URL":"https:\/\/tropmedhealth.biomedcentral.com\/articles\/10.1186\/s41182-020-00288-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["288"],"URL":"https:\/\/doi.org\/10.1186\/s41182-020-00288-7","relation":{},"ISSN":["1349-4147"],"issn-type":[{"value":"1349-4147","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"30 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The SMC programme, and its components such as routine end-of-cycle LQAS surveys, were developed in collaboration with, and approved by, the Nigerian National Malaria Elimination Programme and national Ministry of Health. All respondents provided informed consent for their participation in the survey. The study was conducted in accordance with the principles set out in the Declaration of Helsinki.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. No individual-level has been presented as part of this study. The analysis included in this study was performed using anonymised data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"101"}}